Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pain block showdown: which works best for hernia surgery recovery?

NCT ID NCT07522853

Symptom relief Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different nerve block methods—M-TAPA and OSTAP—to see which provides better pain relief after laparoscopic inguinal hernia repair. 90 adults having surgery were randomly assigned to receive one of the blocks or standard painkillers. Researchers measured pain scores and how much extra pain medication patients needed in the first 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If one block works better, it could mean less pain and less need for painkillers after hernia surgery.
What could go wrong
This is a small, completed study with 90 people, so results may not apply to everyone. Pain relief varies from person to person.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Apr 2025

Finished

Sep 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 18 and 65 years * American Society of Anesthesiologists (ASA) physical status I-II * Scheduled for elective laparoscopic inguinal hernia repair (TEP technique) * Ability to understand and use the Visual Analog Scale (VAS) * Provided written informed consent Exclusion Criteria: * Refusal to participate or inability to provide informed consent * Age under 18 or over 65 years * ASA physical status ≥ III * Coagulopathy (including abnormal INR, thrombocytopenia, or platelet dysfunction) * Infection at the injection site * Known allergy or hypersensitivity to study medications (local anesthetics, NSAIDs, opioids) * Chronic opioid use (longer than 4 weeks) * Use of psychiatric medications affecting pain perception * Inability to cooperate or communicate effectively * Requirement for postoperative intensive care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inguinal hernia bilateral are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hernia, double inguinal Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inguinal hernia bilateral Postoperative pain

Contacts and locations

Locations

  • Kartal Dr. Lütfi Kırdar City Hospital

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.